Coupled D dimer and fibrinogen levels during thrombolytic therapy of venous thromboembolism

Thromb Res. 1992 Feb 1;65(3):457-62. doi: 10.1016/0049-3848(92)90176-b.

Authors

B Jude¹, N Amrouni, I Deguine, A Marey, P Asseman, A Watel, C Thery, P Marache, A Cosson

Affiliation

¹ Laboratoire d'hématologie, Hôpital Cardiologique, Lille, France.

PMID: 1631808
DOI: 10.1016/0049-3848(92)90176-b

No abstract available

MeSH terms

Adolescent
Adult
Aged
Female
Fibrin Fibrinogen Degradation Products / analysis*
Fibrinogen / analysis*
Fibrinolysis
Humans
Male
Middle Aged
Peptide Fragments / therapeutic use
Plasminogen / therapeutic use
Postoperative Complications / blood
Postoperative Complications / drug therapy
Predictive Value of Tests
Prospective Studies
Pulmonary Embolism / blood*
Pulmonary Embolism / complications
Pulmonary Embolism / drug therapy
Streptokinase / therapeutic use
Thrombolytic Therapy*
Thrombophlebitis / blood*
Thrombophlebitis / complications
Thrombophlebitis / drug therapy
Treatment Outcome
Urokinase-Type Plasminogen Activator / therapeutic use

Substances

Fibrin Fibrinogen Degradation Products
Peptide Fragments
fibrin fragment D
lysyl-plasminogen
Fibrinogen
Plasminogen
Streptokinase
Urokinase-Type Plasminogen Activator